Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
5
0
0
HilleVax, Inc. - Common Stock
Share · US43157M1027 · HLVX (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of HilleVax, Inc. - Common Stock
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 45,36 %
Shares Float 22,74 M
Shares Outstanding 50,13 M
Company Profile for HilleVax, Inc. - Common Stock Share
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
Company Data
Name HilleVax, Inc. - Common Stock
Company HilleVax, Inc.
Symbol HLVX
Website
https://www.hillevax.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US43157M1027
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Robert M. Hershberg
Market Capitalization 105 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 75 State Street, 02109 Boston
IPO Date 2022-04-29
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | HLVX |
More Shares
Investors who hold HilleVax, Inc. - Common Stock also have the following shares in their portfolio:
